Myovant Sciences Ltd. Cash and Cash Equivalents
Myovant Sciences Ltd. had Cash and Cash Equivalents of $250.59 million as of 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2023-01-26
- 2022-12-31: Cash and Cash Equivalents, at Carrying Value $250.59M.
- 2022-09-30: Cash and Cash Equivalents, at Carrying Value $341.96M.
- 2022-06-30: Cash and Cash Equivalents, at Carrying Value $325.54M.
- 2022-03-31: Cash and Cash Equivalents, at Carrying Value $406.70M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2022-12-31 | $250.59M 10-Q · filed 2023-01-26 | |
| 2022-09-30 | $341.96M 10-Q · filed 2022-10-26 | |
| 2022-06-30 | $325.54M 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $406.70M 10-Q · filed 2023-01-26 | |
| 2021-12-31 | $457.74M 10-Q · filed 2023-01-26 | |
| 2021-09-30 | $518.16M 10-Q · filed 2022-10-26 | |
| 2021-06-30 | $484.96M 10-Q · filed 2022-07-27 | |
| 2021-03-31 | $674.49M 10-K · filed 2022-05-11 | |
| 2020-12-31 | $713.52M 10-Q · filed 2022-01-26 | |
| 2020-09-30 | $94.21M 10-Q · filed 2021-10-26 | |
| 2020-06-30 | $84.73M 10-Q · filed 2021-07-28 | |
| 2020-03-31 | $76.64M 10-K · filed 2022-05-11 | |
| 2019-12-31 | $83.07M 10-Q · filed 2021-02-11 | |
| 2019-09-30 | $130.37M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $226.73M 10-Q · filed 2020-08-11 | |
| 2019-03-31 | $156.07M 10-K · filed 2021-05-11 | |
| 2018-12-31 | $183.00M 10-Q · filed 2020-02-10 | |
| 2018-09-30 | $153.72M 10-Q · filed 2019-11-12 | $154.32M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $143.03M 10-Q · filed 2019-08-06 | $143.63M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $108.62M 10-K · filed 2020-05-18 | |
| 2017-12-31 | $128.87M 10-Q · filed 2019-02-07 | |
| 2017-09-30 | $129.33M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $154.19M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $180.84M 10-K · filed 2019-05-24 | |
| 2016-12-31 | $192.32M 10-Q · filed 2018-02-13 | |
| 2016-09-30 | $73.00K 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-10 | |
| 2016-03-31 | $0.00 10-K · filed 2018-06-07 | |
| 2016-02-02 | $0.00 10-K · filed 2018-06-07 |